GYRE THERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Gyre Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Gyre Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -69 %, a 75.2% decline year-over-year.
  • Gyre Therapeutics, Inc. annual Return On Assets for 2023 was -217 %, a 3109% decline from 2022.
  • Gyre Therapeutics, Inc. annual Return On Assets for 2022 was 7.21 %.
  • Gyre Therapeutics, Inc. annual Return On Assets for 2021 was -99.1 %, a 94.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -69 -29.6 -75.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -85.5 -18 -26.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -122 -165 -389% Jan 1, 2024 Mar 31, 2024
Q4 2023 -217 -224 -3109% Oct 1, 2023 Dec 31, 2023
Q3 2023 -39.4 -62 -274% Jul 1, 2023 Sep 30, 2023
Q2 2023 -67.5 -54.4 -414% Apr 1, 2023 Jun 30, 2023
Q1 2023 42.4 +158 Jan 1, 2023 Mar 31, 2023
Q4 2022 7.21 +106 Oct 1, 2022 Dec 31, 2022
Q3 2022 22.6 +110 Jul 1, 2022 Sep 30, 2022
Q2 2022 -13.1 +59.2 +81.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -116 -49.5 -74.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -99.1 -48 -94.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -87.8 -41.9 -91.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -72.3 -27.5 -61.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -66.4 -22.5 -51.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -51 +3.73 +6.81% Oct 1, 2020 Dec 31, 2020
Q3 2020 -45.8 +2.98 +6.11% Jul 1, 2020 Sep 30, 2020
Q2 2020 -44.9 -4.62 -11.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -44 -12.5 -39.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -54.8 -32.7 -148% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.8 -27 -124% Jul 1, 2019 Sep 30, 2019
Q2 2019 -40.2 -14.6 -56.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -31.5 +3.18 +9.18% Jan 1, 2019 Mar 31, 2019
Q4 2018 -22.1 +38.4 +63.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -21.8 +33.6 +60.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -25.7 +21.1 +45.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -34.6 +5.12 +12.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -60.5 -28 -86% Oct 1, 2017 Dec 31, 2017
Q3 2017 -55.4 -24.9 -81.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -46.8 -18.5 -65.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -39.8 -10.1 -34% Jan 1, 2017 Mar 31, 2017
Q4 2016 -32.5 -9.31 -40.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -30.6 -7.28 -31.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -28.3 -15.5 -120% Apr 1, 2016 Jun 30, 2016
Q1 2016 -29.7 -20.9 -236% Jan 1, 2016 Mar 31, 2016
Q4 2015 -23.2 -16.2 -231% Oct 1, 2015 Dec 31, 2015
Q3 2015 -23.3 -3.61 -18.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -12.9 +15.7 +54.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -8.82 +25.9 +74.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -7 +29.7 +80.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -19.7 +8.72 +30.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -28.5 -4.62 -19.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -34.8 -25.9 -293% Jan 1, 2014 Mar 31, 2014
Q4 2013 -36.7 -33.3 -996% Oct 1, 2013 Dec 31, 2013
Q3 2013 -28.4 -28 -6783% Jul 1, 2013 Sep 30, 2013
Q2 2013 -23.9 -23.1 -2683% Apr 1, 2013 Jun 30, 2013
Q1 2013 -8.83 -1.78 -25.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -3.35 Oct 1, 2012 Dec 31, 2012
Q3 2012 -0.41 Jul 1, 2012 Sep 30, 2012
Q2 2012 -0.86 Apr 1, 2012 Jun 30, 2012
Q1 2012 -7.06 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.